Neoadjuvant chemotherapy with gemcitabine and S1

2 trials

Sponsors

Miyagi HBPCOG, NEXTSURG

Conditions

resectable pancreatic cancer

Phase 2

Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS3)

Active, not recruitingJPRN-UMIN000003402

Miyagi HBPCOGresectable pancreatic cancer

Start: 2010-04-01Target: 35Updated: 2026-06-29

Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS2+2)

Active, not recruitingJPRN-UMIN000009070

NEXTSURGresectable pancreatic cancer

Start: 2012-10-15Target: 35Updated: 2026-06-29